4 research outputs found

    Regime shifts of Cruces River wetland ecosystem: current conditions, future uncertainties

    No full text
    During April-May 2004 the Cruces River wetland ecosystem, located in Valdivia (40°S), southern Chile, was described as shifting from a clear water regime, dominated by the exotic macrophyte Egeria densa, to turbid waters and absence of submerged macrophytes. We analyzed the trophic status and ecological regime of the wetland from November 2011 through January 2013. The trophic status was determined comparing values of selected variables (nutrients, chlorophyll-a and transparency) with OECD criteria. The ecological regime was determined comparing the same variables with the criteria proposed by Ibelings et al. (2007). We further compared the concentration of nutrients and suspended solids with previous measurements. Current trophic status of the wetland is between eutrophic and hypereutrophic, as shown by results, and its ecological regime intermediate, between clear and turbid waters, with a considerable risk of returning to turbid waters. In this article we discuss the potential relationship between the watershed land use (agriculture, cattle feeding and forestry), the change in wetland's trophic level and future conditions

    Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic

    Get PDF
    Aim This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic. Method This was an international cohort study of patients undergoing elective resection of colon or rectal cancer without preoperative suspicion of SARS-CoV-2. Centres entered data from their first recorded case of COVID-19 until 19 April 2020. The primary outcome was 30-day mortality. Secondary outcomes included anastomotic leak, postoperative SARS-CoV-2 and a comparison with prepandemic European Society of Coloproctology cohort data. Results From 2073 patients in 40 countries, 1.3% (27/2073) had a defunctioning stoma and 3.0% (63/2073) had an end stoma instead of an anastomosis only. Thirty-day mortality was 1.8% (38/2073), the incidence of postoperative SARS-CoV-2 was 3.8% (78/2073) and the anastomotic leak rate was 4.9% (86/1738). Mortality was lowest in patients without a leak or SARS-CoV-2 (14/1601, 0.9%) and highest in patients with both a leak and SARS-CoV-2 (5/13, 38.5%). Mortality was independently associated with anastomotic leak (adjusted odds ratio 6.01, 95% confidence interval 2.58–14.06), postoperative SARS-CoV-2 (16.90, 7.86–36.38), male sex (2.46, 1.01–5.93), age >70 years (2.87, 1.32–6.20) and advanced cancer stage (3.43, 1.16–10.21). Compared with prepandemic data, there were fewer anastomotic leaks (4.9% versus 7.7%) and an overall shorter length of stay (6 versus 7 days) but higher mortality (1.7% versus 1.1%). Conclusion Surgeons need to further mitigate against both SARS-CoV-2 and anastomotic leak when offering surgery during current and future COVID-19 waves based on patient, operative and organizational risks
    corecore